Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo tested to keep advanced breast cancer in check

NCT ID NCT05392608

Summary

This study is testing if adding a drug called alpelisib to the standard hormone therapy fulvestrant can help control advanced breast cancer that has started to grow again while on fulvestrant alone. It is for 130 adults with a specific type of breast cancer (hormone-receptor positive, HER2-negative) that has a particular gene change (PIK3CA mutation). The main goal is to see if this combination can delay the cancer from getting worse again.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASM, BREAST are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Admiraal de Ruyter Ziekenhuis

    Goes, Netherlands

  • Amphia

    Breda, Netherlands

  • Amsterdam UMC

    Amsterdam, Netherlands

  • Antoni van Leeuwenhoek

    Amsterdam, Netherlands

  • Canisius Wilhelmina Ziekenhuis

    Nijmegen, Netherlands

  • Deventer ziekenhuis

    Deventer, Netherlands

  • Elisabeth-TweeSteden Ziekenhuis

    Tilburg, Netherlands

  • Franciscus Gasthuis & Vlietland

    Schiedam, Netherlands

  • Gelre Ziekenhuizen

    Apeldoorn, Netherlands

  • HagaZiekenhuis

    The Hague, Netherlands

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, Netherlands

  • Maasstad Ziekenhuis

    Rotterdam, Netherlands

  • Martini Ziekenhuis

    Groningen, Netherlands

  • Meander Medisch Centrum

    Amersfoort, Netherlands

  • Medisch Centrum Leeuwarden

    Leeuwarden, Netherlands

  • Medisch Spectrum Twente

    Enschede, Netherlands

  • Máxima Medisch Centrum

    Eindhoven, Netherlands

  • Noordwest Ziekenhuisgroep

    Alkmaar, Netherlands

  • Reinier de Graaf Gasthuis

    Delft, Netherlands

  • Rijnstate

    Arnhem, Netherlands

  • Spaarne Gasthuis

    Hoofddorp, Netherlands

  • St. Antonius Ziekenhuis

    Nieuwegein, Netherlands

  • VieCuri Medisch Centrum

    Venlo, Netherlands

  • Ziekenhuis Amstelland

    Amstelveen, Netherlands

  • Ziekenhuisgroep Twente

    Almelo, Netherlands

Conditions

Explore the condition pages connected to this study.